None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. stage 2~4 of CKD patients 2. less than 160/100 mmHg of blood pressure at sitting position in hypertensive patients 3. more than 100 mmHg of systolic pressure at sitting position in normotensive patients
Exclusion criteria
Exclusion criteria: Patients with Uncontrolled hypertension (more than 160/100 mmHg) Vitamin D supplementation Renal artery stenosis or primary aldosteronism Refractory edema immunosuppressive agents
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Association between vitamin D receptor polymorphism and left ventricular hypertrophy | — |
Secondary
| Measure | Time frame |
|---|---|
| association between vitamin D receptor polymorphism and vitamin D concentration;association between vitamin D receptor polymorphism and progression of left ventricular hypertrophy;association between vitamin D receptor polymorphism and progression of kidney dysfunction | — |
Countries
Korea, Republic of
Contacts
Samsung Changwon Medical Center